Thomas Cherrier
Impact in
- Virology top 5%
- HIV Research and Treatment
-
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 8
- HIV Research and Treatment 8
-
- RNA modifications and cancer 3
- Co-authors
- Olivier Rohr (10 shared papers)Christian Schwartz (9 shared papers)Carine Van Lint (4 shared papers)Valentin Le Douce (8 shared papers)Lætitia Redel (6 shared papers)Dominique Aunis (6 shared papers)Aurore Hick (1 shared paper)Kevin Kit Parker (1 shared paper)
- Journals
- Cell Death and Disease (2 papers)Nucleic Acids Research (1 paper)Cellular Signalling (1 paper)Virology Journal (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- FranceBelgiumUnited States
In The Last Decade
Thomas Cherrier
16 papers receiving 521 citations
Peers
Comparison fields: 5 of 69
- Virology 155
- Infectious Diseases 95
- Molecular Biology 334
- Immunology 86
- Neurology 25
Countries citing papers authored by Thomas Cherrier
This map shows the geographic impact of Thomas Cherrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cherrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cherrier more than expected).
Fields of papers citing papers by Thomas Cherrier
This network shows the impact of papers produced by Thomas Cherrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cherrier. The network helps show where Thomas Cherrier may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Cherrier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 190 | |
| 2 | 2009 | 95 | |
| 3 | 2011 | 62 | |
| 4 | 2009 | 51 | |
| 5 | 2013 | 23 | |
| 6 | 2011 | 22 | |
| 7 | 2020 | 21 | |
| 8 | 2011 | 16 | |
| 9 | 2019 | 10 | |
| 10 | 2010 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2010 | 6 | |
| 13 | 2010 | 6 | |
| 14 | 2014 | 3 | |
| 15 | 2010 | 2 | |
| 16 | 2025 | 1 |
About Thomas Cherrier
Thomas Cherrier is a scholar working on Virology, Molecular Biology, Immunology, Hepatology and Infectious Diseases, having authored 16 papers that have together received 523 indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Phagocytosis and Immune Regulation (3 papers), RNA modifications and cancer (3 papers), Hepatitis C virus research (3 papers), Immune cells in cancer (3 papers), Immune Cell Function and Interaction (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers) and HIV-related health complications and treatments (2 papers). The work is most often cited by research in Virology (155 citations), Infectious Diseases (95 citations), Molecular Biology (334 citations), Immunology (86 citations) and Neurology (25 citations). Thomas Cherrier has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Olivier Rohr, Christian Schwartz, Carine Van Lint, Valentin Le Douce, Lætitia Redel, Dominique Aunis, Aurore Hick, Kevin Kit Parker, Jérome Chal and Ziad Al Tanoury. Their work appears in journals such as Cell Death and Disease, Nucleic Acids Research, Cellular Signalling, Virology Journal and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.